- Home
- CIK vs TSVT Comparison
CIK vs TSVT Comparison
Compare CIK & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIK
- TSVT
- Stock Information
- Founded
- CIK 1987
- TSVT 2021
- Country
- CIK United States
- TSVT United States
- Employees
- CIK N/A
- TSVT N/A
- Industry
- CIK Finance/Investors Services
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- CIK Finance
- TSVT Health Care
- Exchange
- CIK Nasdaq
- TSVT Nasdaq
- Market Cap
- CIK 162.5M
- TSVT 160.4M
- IPO Year
- CIK N/A
- TSVT N/A
- Fundamental
- Price
- CIK $3.00
- TSVT $3.61
- Analyst Decision
- CIK
- TSVT Buy
- Analyst Count
- CIK 0
- TSVT 6
- Target Price
- CIK N/A
- TSVT $10.40
- AVG Volume (30 Days)
- CIK 115.4K
- TSVT 356.3K
- Earning Date
- CIK 01-01-0001
- TSVT 11-12-2024
- Dividend Yield
- CIK 9.03%
- TSVT N/A
- EPS Growth
- CIK N/A
- TSVT N/A
- EPS
- CIK N/A
- TSVT N/A
- Revenue
- CIK N/A
- TSVT $45,620,000.00
- Revenue This Year
- CIK N/A
- TSVT N/A
- Revenue Next Year
- CIK N/A
- TSVT $31.98
- P/E Ratio
- CIK N/A
- TSVT N/A
- Revenue Growth
- CIK N/A
- TSVT N/A
- 52 Week Low
- CIK $2.50
- TSVT $1.68
- 52 Week High
- CIK $3.19
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- CIK 51.81
- TSVT 38.02
- Support Level
- CIK $2.93
- TSVT $4.81
- Resistance Level
- CIK $2.99
- TSVT $5.12
- Average True Range (ATR)
- CIK 0.03
- TSVT 0.33
- MACD
- CIK 0.00
- TSVT -0.12
- Stochastic Oscillator
- CIK 87.50
- TSVT 28.10
About CIK Credit Suisse Asset Management Income Fund Inc.
Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations, and individuals.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.